Postoperative controls |  | Antiseptics Application | A: 1 + 2 weeks B: 3 + 4 weeks C: 5+ weeks | Maintenance protocol in the first 2 months | 1: ≤ 2x 2: ≥ 3x | |||
---|---|---|---|---|---|---|---|---|
Study | Antiseptic | Galenic formulation | Application frequency | Duration | Category | Supragingival cleaning | Intervals (weeks) | Category |
Van Winkelhoff et al. 1992 | n.r. |  |  |  |  | n.r. | clinical measurements at 3 to 9 months (4.9 ± 2 months) |  |
Winkel et al. 1998 | n.r. | Â | Â | Â | Â | hygiene instructions | week 21 | 1 |
Müller et al. 1998 | CHX | 0.10 % | n. r. | 2 weeks | A | n.r. | clinical measurements at 3 months |  |
Flemmig et al. 1998 | CHX | 0.06Â % | 1x/d | 8Â days | A | yes | 10Â days, 3, 6, 9 and 12Â months | 1 |
Berglundh et al. 1998 | n.r. | Â | Â | Â | Â | n.r. | clinical parameters at 2 and 12Â months | Â |
Winkel et al. 2001 | n.r. | Â | Â | Â | Â | yes | week 6 | 1 |
Ehmke et al. 2003 | CHX | 0.06Â % | 1x/d | 8Â days | A | yes | 3, 6, 9, 12, 18, 24Â months | 1 |
Guerrero et al. 2005 | CHX | 0.2Â % | 2x/d | 2Â weeks | A | yes | 2 and 6Â months | 1 |
Mombelli et al. 2005 | n.r. | Â | Â | Â | Â | yes | 10Â days, 2, 6 and 12Â months | 1 |
Ehmke et al. 2005 | CHX | 0.06Â % | 1x/d | 8Â days | A | yes | 3, 6, 9, 12, 18, 24Â months | 1 |
Xajigeorgiou et al. 2006 | n.r. | Â | Â | Â | Â | yes | week 6 | 1 |
Giannopoulou et al. 2006 | n.r. | Â | Â | Â | Â | n.r. | clinical parameters at 10Â days, 2, 6 and 12Â months | Â |
Moeintaghavi et al. 2007 | n.r. | Â | Â | Â | Â | n.r. | Â | Â |
Kaner et al. 2007 | CHX | 0.2Â % | 2x/d | 2Â weeks | A | yes | 3 and 6Â months | 1 |
Moreira et al. 2007 | CHX | 0.12Â % | 2x/d | 2Â months | C | yes | 3Â month | 1 |
Guerrero et al. 2007 | CHX | 0.12Â % | 2x/d | 2Â weeks | A | yes | 2Â months | 1 |
Machtei et al. 2008 | n.r. | Â | Â | Â | Â | oral hygiene motivation | every 2nd week for 3Â months | 2 |
Johnson et al. 2008 | CHX | 0.12Â % | 2x/d | 30Â days | C | n.r. | clinical parameters at 3 and 6Â months | Â |
Akincibay et al. 2008 | n.r. | Â | Â | Â | Â | n.r. | clinical measurements at 30, 60, 90Â days | Â |
Valenza et al. 2009 | n.r. | Â | Â | Â | Â | yes | 2, 6 and 12Â months | 1 |
Del Peloso et al. 2009 | n.r. | Â | Â | Â | Â | yes | every month for 6Â months | 1 |
Cionca et al. 2009 | CHX | 0.2Â % | 2x/d | 10Â days | A | yes | 1Â week, 3 and 6Â months | 1 |
Yek et al. 2010 | n.r. | Â | Â | Â | Â | yes | monthly up to 6Â months | 1 |
Cionca et al. 2010 | CHX | 0.2Â % | 2x/d | 10Â days | A | yes | 1Â week, 3 and 6Â months | 1 |
Mestnik et al. 2010 | CHX | 0.12Â % | 2x/d | 60Â days | C | n.r. | clinical measurements at 3Â months | Â |
Heller et al. 2011 | CHX | 0.12Â % | 2x/d | 45Â days | C | yes | 3Â months | 1 |
Rodrigues et al. 2011 | n.r. | Â | Â | Â | Â | yes | 1, 3 and 6Â months | 1 |
Silva et al. 2011 | n.r. | Â | Â | Â | Â | n.r. | clinical measurements at 3Â months | Â |
Varela et al. 2011 | CHX | 0.12Â % | 2x/d | 45Â days | C | yes | 3Â months | 1 |
Baltacioglu et al. 2011 | n.r. | Â | Â | Â | Â | n.r. | clinical measurements at 2Â months | Â |
Aimetti et al. 2012 | CHX | 0.2Â % | 2x/d | 2Â months | C | yes | every 2nd week for 6Â weeks, then every 2Â months up to 6Â months | 2 |
Casarin et al. 2012 | n.r. | Â | Â | Â | Â | n.r. | clinical measurements at 3 and 6Â months | Â |
Goodson et al. 2012 | CHX | 0.12Â % | 2x/d | 2Â weeks | A | yes | 3, 6, 12, 18, 24Â months | 2 |
Oliveira et al. 2012 | CHX | 0.12Â % | 2x/d | 60Â days | C | n.r. | clinical measurements at 6Â months | Â |